Selective COX-2 inhibitors: where do we go from here?
D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D013450:Sulfones / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced*
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib